| Full text | |
| Author(s): |
Total Authors: 3
|
| Affiliation: | [1] Univ Estadual Campinas UNICAMP, Programa Fisiopathol, Campinas, SP - Brazil
[2] Univ Montreal, Dept Med, Montreal, PQ - Canada
Total Affiliations: 2
|
| Document type: | Journal article |
| Source: | NEUROCHEMISTRY INTERNATIONAL; v. 112, p. 134-145, JAN 2018. |
| Web of Science Citations: | 1 |
| Abstract | |
Development of manganism (also known as manganese neurotoxicity) is a major complication of manganese exposure in which neurological dysfunction is linked to accumulation of the metal in brain. Due to neuronal cell death in basal ganglia structures, particularly the globus pallidus, functional recovery is limited. Bearing a resemblance to Parkinson's disease, effective treatment for manganism is currently limited. However, the rapidly developing field of stem cell research offers new hope for the treatment of illnesses in which neurodegeneration is a major feature. The first part of this review will focus on the clinical features and pathophysiology of cerebral damage resulting from exposure to manganese, including the role of astrocytes, disruption of energy metabolism, involvement of oxidative stress, excitotoxicity, and inflammation, with the second part exploring how stem cells may provide an important therapeutic strategy for patients with this major neurologic disorder. (C) 2017 Elsevier Ltd. All rights reserved. (AU) | |
| FAPESP's process: | 11/02263-3 - Pathophysiology of cerebral glutamate transport dysfunction in acute liver failure |
| Grantee: | Alan Stewart Hazell |
| Support type: | Regular Research Grants |
| FAPESP's process: | 13/07559-3 - BRAINN - The Brazilian Institute of Neuroscience and Neurotechnology |
| Grantee: | Fernando Cendes |
| Support type: | Research Grants - Research, Innovation and Dissemination Centers - RIDC |
| FAPESP's process: | 11/02295-2 - Astrocyte-mediated excitotoxicity in manganism |
| Grantee: | Alan Stewart Hazell |
| Support type: | Regular Research Grants |